Anita Andreano1, Stefania Galimberti1, Elvira Franza2, Erica M Knavel3, Sandro Sironi2, Fred T Lee3, Maria Franca Meloni4. 1. Department of Health Sciences, University of Milano-Bicocca, Monza; Centre of Biostatistics for Clinical Epidemiology, University of Milano-Bicocca, Monza. 2. Department of Health Sciences, University of Milano-Bicocca, Monza. 3. Department of Radiology, University of Wisconsin, Madison, Wisconsin. 4. Department of Health Sciences, University of Milano-Bicocca, Monza; Department of Radiology, Ospedale Valduce, via Dante 11, Como 22100, Italy. Electronic address: meloni.mariafranca@gmail.com.
Abstract
PURPOSE: To prospectively investigate the frequency and severity of postablation syndrome (PAS) and postprocedural pain in a cohort of patients undergoing hepatic microwave ablation. MATERIALS AND METHODS: From March 2009 to November 2011, 54 consecutive patients undergoing microwave ablation for liver tumors were enrolled. A questionnaire was administered to investigate PAS and pain at 1, 7, and 40 days after ablation. Four patients did not complete all three questionnaires and were excluded from the analysis. Additionally, laboratory tests with results known to significantly increase or decrease after ablation were performed, and ablation parameters were recorded. Potential predictors of PAS and pain at 1 and 7 days were evaluated by a logistic regression model. RESULTS: Fifty patients underwent a single microwave ablation session, 33 for hepatocellular carcinoma (HCC) and 17 for liver metastasis. Median ablation volumes on computed tomography were 31 cm(3) for HCC and 42 cm(3) for metastasis. Sixty percent of patients experienced PAS in the first week. Aspartate aminotransferase (AST) levels after ablation were significantly associated with PAS during postprocedure days 1-7. Median visual analog scale scores for pain at the puncture site were 1 and 0.24 at 1 and 7 days, respectively. The risk of having at least moderate pain in the first week was significantly related to ablation volume and time and postablation increase in AST level. CONCLUSIONS: The incidence and severity of PAS with hepatic microwave ablation is similar to that reported for radiofrequency ablation, with the best predictive factor being postablation AST level elevation. Postablation pain was best predicted by total ablation volume and AST level.
PURPOSE: To prospectively investigate the frequency and severity of postablation syndrome (PAS) and postprocedural pain in a cohort of patients undergoing hepatic microwave ablation. MATERIALS AND METHODS: From March 2009 to November 2011, 54 consecutive patients undergoing microwave ablation for liver tumors were enrolled. A questionnaire was administered to investigate PAS and pain at 1, 7, and 40 days after ablation. Four patients did not complete all three questionnaires and were excluded from the analysis. Additionally, laboratory tests with results known to significantly increase or decrease after ablation were performed, and ablation parameters were recorded. Potential predictors of PAS and pain at 1 and 7 days were evaluated by a logistic regression model. RESULTS: Fifty patients underwent a single microwave ablation session, 33 for hepatocellular carcinoma (HCC) and 17 for liver metastasis. Median ablation volumes on computed tomography were 31 cm(3) for HCC and 42 cm(3) for metastasis. Sixty percent of patients experienced PAS in the first week. Aspartate aminotransferase (AST) levels after ablation were significantly associated with PAS during postprocedure days 1-7. Median visual analog scale scores for pain at the puncture site were 1 and 0.24 at 1 and 7 days, respectively. The risk of having at least moderate pain in the first week was significantly related to ablation volume and time and postablation increase in AST level. CONCLUSIONS: The incidence and severity of PAS with hepatic microwave ablation is similar to that reported for radiofrequency ablation, with the best predictive factor being postablation AST level elevation. Postablation pain was best predicted by total ablation volume and AST level.
Authors: Colin M Harari; Michelle Magagna; Mariajose Bedoya; Fred T Lee; Meghan G Lubner; J Louis Hinshaw; Timothy Ziemlewicz; Christopher L Brace Journal: Radiology Date: 2015-07-02 Impact factor: 11.105
Authors: Maria Franca Meloni; Jason Chiang; Paul F Laeseke; Christoph F Dietrich; Angela Sannino; Marco Solbiati; Elisabetta Nocerino; Christopher L Brace; Fred T Lee Journal: Int J Hyperthermia Date: 2016-08-02 Impact factor: 3.914
Authors: Niklas Verloh; Isabel Jensch; Lukas Lürken; Michael Haimerl; Marco Dollinger; Philipp Renner; Philipp Wiggermann; Jens Martin Werner; Florian Zeman; Christian Stroszczynski; Lukas Philipp Beyer Journal: Radiol Oncol Date: 2019-03-03 Impact factor: 2.991
Authors: Robbert S Puijk; Valentijn Ziedses des Plantes; Sanne Nieuwenhuizen; Alette H Ruarus; Laurien G P H Vroomen; Marcus C de Jong; Bart Geboers; Caroline J Hoedemaker-Boon; Deirdre H Thöne-Passchier; Ceylan C Gerçek; Jan J J de Vries; Petrousjka M P van den Tol; Hester J Scheffer; Martijn R Meijerink Journal: Cardiovasc Intervent Radiol Date: 2019-06-26 Impact factor: 2.740